According to
Clinical Trials Today, Pfizer plans to publicly report payments made to clinical investigators, physicians and other health care professionals by early next year, making it the first pharmaceutical company to commit to disclosing payments it makes for conducting clinical trials, speaking and consulting. It seems that Pfizer wants to aim for transparency of their practices, perhaps providing an easier system of due diligence within the pharmaceutical and CRO/Clinical Trials arenas. What do you think of this move by Pfizer?
|
Share this article with your social network, just click below to share now!
|
|
|
photo credit: @KimTweetsDC For over 20 years we have been working hard on delivering you with first-hand insights into one of the mo...
Oren Levy from Karp Lab gave an excellent talk called “MSCs on Steriods” last month at Biotech Week Boston. Oren's research focus is &q...
If you blink you will most likely miss some major design, invention or discovery in the robotics industry. The future is definitely here, an...
No comments :
Post a Comment